Detail akcie HBM Healthcare N online

Business Summary: HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Financial Summary: BRIEF: For the nine months ended 31 December 2023, HBM Healthcare Investments AG revenues decreased 6% to -SF139.1M. Net loss increased 2% to SF157.5M. Revenues reflect Realised gains decrease of 63% to SF69.7M, Dividend income from investment in subsi decrease of 88% to SF1.5M, Gains from currency hedging transactions decrease from SF10.3M to SF0K. Higher net loss reflects Personnel expenses increase from SF559K to SF1.2M (expense).